StockWatch
·
APOLLO TYRES LTD. · QQ1 FY-2027 · THE CALL

Growth masks margin squeeze; commodity cycle turn critical

The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.

Q1 FY27 resultsAPOLLOTYREAPOLLO TYRES LTD.16 Aug 2026 · 6 min read
Verdict

Hold

confidence 6/10

Credibility

Grade B

Guided margin pressure delivered; but Europe margins lagging expectations (8.9% vs 10.8% prior). TBR share regained as claimed.

Short-term outlook

Cautiously Optimistic

next 1–2 quarters

Long-term outlook

Optimistic

multi-year

India volume momentum (+15.6%) and market share recovery (TBR 30%, PC 21%) are genuine, but Q1 EBITDA margin down 150 bps despite 7-9% pricing shows commodity headwinds overpowering. Net profit margin at 4.7% (vs 12.1% OPM) suggests high depreciation/interest from CapEx cycle. Europe restructuring benefits pushed to H2, execution risk real. Hold until commodity cycle stabilizes and margin recovery proves visible in Q2.

₹7397.8 Cr

Revenue · +12.8% YoY

₹348.9 Cr

Reported PAT · +2609.1% YoY

Compressing

Margins · vs guidance: Mixed

Did the claims hold up?

Management's claims vs. the numbers

Strong consolidated top-line growth of 12.8% Y-o-Y

MET

Delivered 12.8% YoY revenue growth to ₹7397.8 Cr

EBITDA margin 11.7%, down 150 bps YoY on RM cost pressures

MET

Margin compression confirmed; but net profit margin only 4.7% shows profit quality weak

Largely successfully defended margins through calibrated price hikes

OVERSTATED

Only 3-4% price flowed to revenue; still need 15-16% total while at 11%+; margins compressed not defended

Raw material costs escalated sharply by nearly 17%

MET

India RM up 17%, Europe RM up 8% (natural rubber led Q1, synthetics/energy to hit Q2)

India Operations recorded highest ever revenue with 15.6% YoY growth

MET

₹546 Cr India revenue, +15.6% YoY (12% volume, 3-4% price from staggered implementation)

Earnings quality

What changed since the last call

Deltas vs. the prior call

Price hike magnitude raised

Upgrade

Q4 FY26 guidance 6-8%; Q1 delivered 7-9% implemented (in-range). But still need total 15-16%, now at 11%+. Guidance redlined but not formally raised

Europe margin recovery delayed

Downgrade

Enschede closure impact larger than guided; now showing 8.9% margin (vs 10.8% prior), not the targeted teens yet. High-teens aspiration pushed to full-year post-restructuring

Capacity ramp-up timing clarified

Neutral

Hungary H2 FY27, India end of FY27 (earlier expected). Tight utilization (90%+) confirms demand strength claimed. CapEx >₹3000 Cr on track

CFO departure announced

Withdrawn

Gaurav Kumar leaving after 22+ years; no successor named. Creates transition risk and removes key voice on margin/capex discipline (new)

The Q&A

Moderate. Analysts pressed on: pricing lag vs volume credit (Siddhartha), Europe high-end agri offtaking viability (Amyn, Vijay), pre-buy risk (Vijay—management dodged), pricing power sustainability (Joseph). Management held firm on industry discipline and demand strength, but hedged on Europe timelines and acknowledged 1-2 quarters needed for agri stabilization.

The exchanges that mattered

Volume breakdown & segment growth — Raghunandan NL, not stated

Answered

Replacement 13%, OEM 10%, exports 15%. Barring TBB, all double-digit. Replacement momentum strong; Q2 seasonally weak but YoY growth expected robust

Europe anti-dumping duty impact — Raghunandan NL

Partial

Positive for domestic players. PCR replacement already double-digit ahead of market. Muted top-line due to agri/truck radial transitions (revenue loss known). Europe ops to accelerate forward

Capacity shifting transition — Raghunandan NL

Answered

12-month process from Sep 2025 clearance, completing Sep-Oct 2026. Netherlands 750k units mix: bulk to Hungary, low-end (14-15" tyres) to India. Spacemaster to Baroda (OEM clearances done)

Commodity price pass-through — Raghunandan NL

Answered

India: 17% RM rise, ~11-12% needed (2/3 rule), 7-9% taken Q1 (3-4% flowed revenue). Europe: 8% Q1 RM, 10% needed for Q1-Q2, only 3-4% taken. Q2 more hikes announced; further increases needed

Volume-led growth reconciliation — Siddhartha Bera

Answered

12% from volume, 3-4% from price. Three staggered price hikes through Q1; only partial flow to revenue. Full effect hits Q2 onwards. OEM formula pricing has 1Q lag, starts Q2

Capacity expansion funding — Siddhartha Bera

Answered

Q1 CapEx ₹650 Cr (₹500 Cr India). Will rise Q2, Q3. Expect net debt/EBITDA to rise slightly; will be net borrower. CapEx definitely started

Europe EBITDA without transition costs — Amyn Pirani

Partial

Without overlaps, ~11% EBITDA (vs 8.9% now). Full-year Europe target: high-teens EBITDA. That's the potential once manufacturing footprint optimized for brand/categories

High-end agri medium-term plan — Amyn Pirani

Partial

OHT capacity limited to Kalamassery (Kochi urban constraints). New plant 10-15 tonnes uneconomic (Enschede was 20 MT/day). Identified offtake partner 'at cusp of Asia-Europe.' Medium-term: continue offtake; setting/certifying partner took time

Price hike magnitude details — Vijay Pandey

Answered

July: 1-2% announced. August: typical 2% range (no final info). Need 1-2 more to reach 15-16% total. RM still rising Q2 (8% sequential)

Europe agri offtake quantum & pre-buy — Vijay Pandey

Dodged

20-25% agri offtaken; two partners (product-dependent). Stabilization needs couple quarters. On pre-buy: 'can't give conclusive answer, will get back to you' (dodged)

OEM vs replacement pricing lag — Yash Agarwal

Answered

OEM formula pricing: 1Q lag (Q1 increases hit Q2). OEM truck side: negotiated, dialogues opened Q1, increases starting Q2 (slow process, OEMs under cost pressure too)

Demand outlook: El Niño, high base — Yash Agarwal

Partial

Possible always. But surprised by sustained demand quantum. July strong YoY, volumes rising. Q2 seasonally weaker but YoY growth still strong. Macro uncertain

RM currency impact breakdown — Basudev Banerjee

Answered

Rupee depreciation (₹88→₹90): 7-8% of 25% rise. ~50% RM imported; domestic RM aligns to landed cost of imports globally. Domestic rubber INR 5 cheaper than import parity but follows import price moves

Natural rubber & crude pricing — Basudev Banerjee

Answered

Rubber not hit by West Asia crisis; expect cool from Q3 as seasonal impact goes. Crude has 1Q lag; benefit from $110→$85 Brent to come in. Include synthetic rubber; less cost push into Q1

Margin recovery if commodity deflates — Basudev Banerjee

Partial

Best margins historically when RM cycle cools. Near-term demand strong should play favorably. But won't be here to see credit. Definitely favorable if plays out (hedged)

Industry pricing discipline — Joseph George

Answered

Cost push unprecedented. All players dire straits w/o price increases. Strong demand (mid-to-high teens growth) + high utilization enabled steeper hikes than historical

Reifen subsidiary performance — Joseph George

Answered

EUR 43 million revenue; ~3% EBITDA margin

Price correction if RM falls & demand softens — Vijay Pandey (follow-up)

Partial

Hard to predict. Depends magnitude of RM drop vs demand. Historically best margins in falling RM scenario. But significant RM decline + muted demand may see Q4 price correction (hedged)

Domestic vs import rubber sourcing — Vijay Pandey

Answered

50-50 domestic/international with switching ability (partial, not complete short-term). As intl cools, domestic must follow parity. Won't sustain disparity globally

Market share gains — Aniket Mhatre

Answered

Internal estimates (no industry data). TBR replacement ~30% (regained share), PC replacement ~21% (higher than prior)

Guidance

Forward guidance and management's confidence

India Q2: 8% sequential RM inflation expected; need 15-16% cumulative price hikes (at 11%+ currently)

High

RM expected 8% sequential Q2 (vs 17% in Q1). Already announced July 1-2%, August ~2% expected. Need 1-2 more hikes into H2

Europe growth to accelerate from restructuring benefits H2 FY27

Medium

Enschede overlap costs to end; truck radial/agri transitions ~stabilized couple quarters. Agri 20-25% offtake unstable. Anti-dumping duty tailwind timing unclear

EBITDA expected to recover if commodity cycle stabilizes from Q3, with margin expansion from full price hike flow

Medium

5-odd price increases to fully flow into H2 revenues if RM stabilizes. Rubber expected to cool Q3 onwards; Brent benefit (1Q lag) also Q3+. Conditional on macro

Europe high-teens EBITDA aspiration on full-year basis post-restructuring (no FY-specific target given)

Low

Currently 8.9%; without Enschede overlaps would be 11%. High-teens implies 16%+ but depends on PCR growth (double-digit claimed) and agri stabilization (couple quarters)

FY27 CapEx >₹3000 Cr (India bulk, Hungary strategic expansion). Q1 CapEx ₹650 Cr (₹500 Cr India)

High

India: 12-month normal run ₹1200-1300 Cr, expansion on track; Hungary +4,000 car tyres/day, India +double that. Start production H2 FY27 (Hungary) and end FY27 (India)

Risks the call surfaced

Ranked by how much they should concern a holder

Commodity cycle / Raw material inflation

High

RM basket up 17% in Q1 (natural rubber +40% seasonal). Expect 8% more Q2 before relief Q3. If West Asia tension persists or monsoon delayed, cycle extends into H2, margin recovery deferred

Europe margin recovery execution

High

Europe EBITDA 8.9% vs 10.8% prior; aspiration is high-teens post-restructuring but unquantified. Agri segment offtaking 20-25% (two partners, customized specs). Stabilization needs 'couple quarters.' If PCR doesn't double-digit accelerate or offtake partners fail, high-teens unachievable

Pricing power sustainability / ASP correction risk

Medium

Management took 7-9% price hikes and claims industry discipline. But if RM falls sharply (rubber from ₹260 back to ₹200) and demand softens (high base H2, El Niño risk), ASP correction in Q4 possible. Replacement market historically competitive; steeper hikes never seen in 10-15 years may not hold if market turns

CFO departure / leadership transition

Medium

Gaurav Kumar leaving to pursue 'new challenge' after Enschede project completion. No interim/permanent successor named. Creates risk on capex prioritization, leverage tolerance, margin target discipline, and investor communication continuity. Finance decisions (debt ramp for ₹3000+ Cr CapEx) now uncertain on ownership

Capacity ramp-up execution / capex overrun

Medium

Q1 CapEx ₹650 Cr; >₹3000 Cr guided for FY27. India capacity to come on-stream end of year, ramp through FY28. Hungary starting H2. If delays occur or costs escalate (25%+ inflationary environment), net debt-to-EBITDA rise accelerates. Currently 0.4x, expected to 'rise slightly,' but overruns could push to 1.0x+

Management

Score 7/10. Clear on operational metrics (volumes, pricing, segment numbers) and forward assumptions (RM inflation, price hike phasing). Transparent on challenges (Enschede impact, Europe margin lag, agri offtake dependency). CFO departure announcement handled directly but without succession plan disclosed, creating uncertainty signal. Track record mixed: guided 6-8% price hikes, delivered 7-9% ✓. Guided margin pressure delivered ✓. But Europe margin guidance slipped (10.8% region not met; 8.9% delivered; high-teens aspiration now hedged). Enschede benefits timeline deferred to H2. Capacity ramp timing clarified (H2 Hungary, end-FY India) but execution risk real on Q1 pace.

What to watch next
  • 1 · Sep-Oct 2026

    Enschede restructuring overlap costs end; European margin step-up expected

  • 2 · Oct-Dec 2026

    Hungary capacity ramp-up from 17k to 21k car tyres/day starts; high-teens margin potential

  • 3 · Q3 FY27

    Commodity cycle expected to reverse; rubber prices cooling from seasonal highs (₹225→₹260 in Q2, down in Q3)

Hold until commodity cycle stabilizes and margin recovery proves visible in Q2.

Informational and educational content only. Not investment advice.